Similar to iPSC, P19teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types.
Similar to iPSC, P19teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types.
Similar to iPSC, P19teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types.
Similar to iPSC, P19teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types.
Similar to iPSC, P19teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types.
Similar to iPSC, P19teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types.
To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human).
To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human).
To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human).
To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human).
To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human).
To address this issue we employed a murine embryonic stem cell line (ES-D3) as well as two teratocarcinoma cell lines, P19 (murine) and NTera2 (human).
Using P19teratocarcinoma cells differentiated by retinoic acid treatment, we observed an induction of Ret mRNA accompanied by a decrease of SP1 binding due to its proteolytic cleavage.
Using P19teratocarcinoma cells differentiated by retinoic acid treatment, we observed an induction of Ret mRNA accompanied by a decrease of SP1 binding due to its proteolytic cleavage.
Using P19teratocarcinoma cells differentiated by retinoic acid treatment, we observed an induction of Ret mRNA accompanied by a decrease of SP1 binding due to its proteolytic cleavage.
Using P19teratocarcinoma cells differentiated by retinoic acid treatment, we observed an induction of Ret mRNA accompanied by a decrease of SP1 binding due to its proteolytic cleavage.
Using P19teratocarcinoma cells differentiated by retinoic acid treatment, we observed an induction of Ret mRNA accompanied by a decrease of SP1 binding due to its proteolytic cleavage.
Using P19teratocarcinoma cells differentiated by retinoic acid treatment, we observed an induction of Ret mRNA accompanied by a decrease of SP1 binding due to its proteolytic cleavage.
Synaptophysin and synapsin I, another synaptic vesicle protein, are also expressed by retinoic acid-induced neuronally differentiated P19teratocarcinoma cells.